Press releases
- Press releases
- Browse
Press releases
Lake Park, Florida - TransDermal Technologies, Inc. announced today the release of its latest pre-clinical data validating its patent-pending, patchless, liquid transdermal delivery system, TDS(R) in the delivery of Ibuprofen. More
Two new Clinical Study reports of Neo-Penotran® Forte are to be presented at the 10'th International Congress on Infectious Diseases meeting to be held in Singapore between 11-14 March 2002. More
HEALTHPOINT Canada, a division of HEALTHPOINT Ltd., , began marketing COOK Biotech Incorporated's patented wound matrix product, Oasis, in Canada this month through a distribution partnership with Trudell Medical Marketing Limited. More
Triseptin® Meets New CDC Guidelines for Surgical Scrubbing More
"MENOPUR(tm) is at least as effective and well tolerated as genetically-engineered, so called recombinant FSH in women undergoing in-vitro fertilisation treatment" More
Patents were recently granted in 12 new countries for SULIDIN® LPS® (Topical Nimesulide Gel). Licensees are sought in these and other territories worldwide. More
Zambon and APR have recently signed a Strategic Alliance and License Agreement for the further development and marketing of innovative patented consumer oriented products in patch form. More
Two new studies on the Efficacy, Tolerability and Safety of Kortos® HC cream and Kortos® HC Suppository have been carried out, found to be highly efficacous and well tolerated with no clinically relevant systemic or local side/adverse effects More
Zambon and Fournier signed a license agreement for the development of new chemical entities from Fournier's know-how and patents on Interleukin-4 (IL-4) antagonists and Interleukin-4/Interleukin-5 (IL-4/IL-5) secretion inhibitors More
Questcor Signs Agreement With Beacon Pharmaceuticals to Market H.P. Acthar Gel in the United Kingdom
Questcor Pharmaceuticals has signed an agreement with Beacon Pharmaceuticals of Tunbridge Wells, Kent, UK, for the exclusive marketing and distribution of H.P. Acthar(R) Gel in the United Kingdom. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2009 - 16 pages - $595
Apr 2008 - 38 pages - $2,295
Mar 2009 - 14 pages - $595
Apr 2008 - 41 pages - $2,295
Apr 2008 - 44 pages - $2,295
Apr 2008 - 42 pages - $2,295
Apr 2008 - 44 pages - $2,295
Apr 2008 - 42 pages - $2,295
Mar 2009 - 12 pages - $595
Apr 2008 - 44 pages - $2,295
Your selection
- Year
- 2002 del
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us